Literature DB >> 10618637

Evidence for regulation of amelogenin gene expression by 1,25-dihydroxyvitamin D(3) in vivo.

P Papagerakis1, D Hotton, F Lezot, S Brookes, W Bonass, C Robinson, N Forest, A Berdal.   

Abstract

The unique hereditary enamel defect clearly related to the disturbance of one enamel matrix protein is X-linked amelogenesis imperfecta (AI), in which several mutations of amelogenin gene have been identified. The clinical phenotype of many of these subjects shows similarities with enamel defects related to rickets. Therefore, we hypothesized that rachitic dental dysplasia is related to disturbances in the amelogenin pathway. In order to test this hypothesis, combined qualitative and quantitative studies in experimental vitamin D-deficient (-D) rat model systems were performed. First, Western blot analysis of microdissected enamel matrix (secretion and maturation stages) showed no clear evidence of dysregulation of amelogenin protein processing in -D rats as compared with the controls. Second, the ultrastructural investigation permitted identification of the internal tissular defect of rachitic enamel, the irregular absence of intraprismatic enamel observed in -D animals, suggesting a possible link between prism morphogenesis and vitamin D. In addition, the steady-state levels of amelogenin mRNAs measured in microdissected dental cells was decreased in -D rats and up-regulated by an unique injection of 1,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)). The present study shows evidences that amelogenin expression is regulated by vitamin D. This is the first study of an hormonal regulation of tooth-specific genes. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10618637     DOI: 10.1002/(sici)1097-4644(20000201)76:2<194::aid-jcb4>3.0.co;2-u

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  8 in total

1.  Bipartite pattern discovery by entropy minimization-based multiple local alignment.

Authors:  Chengpeng Bi; Peter K Rogan
Journal:  Nucleic Acids Res       Date:  2004-09-23       Impact factor: 16.971

2.  Molecular and circadian controls of ameloblasts.

Authors:  Maria Athanassiou-Papaefthymiou; Doohak Kim; Lindsay Harbron; Silvana Papagerakis; Santiago Schnell; Hidemitsu Harada; Petros Papagerakis
Journal:  Eur J Oral Sci       Date:  2011-12       Impact factor: 2.612

3.  Enamel protein regulation and dental and periodontal physiopathology in MSX2 mutant mice.

Authors:  Muriel Molla; Vianney Descroix; Muhanad Aïoub; Stéphane Simon; Beatriz Castañeda; Dominique Hotton; Alba Bolaños; Yohann Simon; Frédéric Lezot; Gérard Goubin; Ariane Berdal
Journal:  Am J Pathol       Date:  2010-10-07       Impact factor: 4.307

4.  Distal cis-regulatory elements are required for tissue-specific expression of enamelin (Enam).

Authors:  Yuanyuan Hu; Petros Papagerakis; Ling Ye; Jerry Q Feng; James P Simmer; Jan C-C Hu
Journal:  Eur J Oral Sci       Date:  2008-04       Impact factor: 2.612

5.  Identifying promoter elements necessary for enamelin tissue-specific expression.

Authors:  Petros Papagerakis; Yuanyuan Hu; Ling Ye; Jerry Q Feng; James P Simmer; Jan C-C Hu
Journal:  Cells Tissues Organs       Date:  2008-08-15       Impact factor: 2.481

6.  Toward Preventing Enamel Hypoplasia: Modeling Maternal and Neonatal Biomarkers of Human Calcium Homeostasis.

Authors:  Susan G Reed; Cameron S Miller; Carol L Wagner; Bruce W Hollis; Andrew B Lawson
Journal:  Caries Res       Date:  2019-10-30       Impact factor: 4.056

7.  Distribution of the amelogenin protein in developing, injured and carious human teeth.

Authors:  Thimios A Mitsiadis; Anna Filatova; Gianpaolo Papaccio; Michel Goldberg; Imad About; Petros Papagerakis
Journal:  Front Physiol       Date:  2014-12-10       Impact factor: 4.566

8.  Expression of Steroid Receptors in Ameloblasts during Amelogenesis in Rat Incisors.

Authors:  Sophia Houari; Sophia Loiodice; Katia Jedeon; Ariane Berdal; Sylvie Babajko
Journal:  Front Physiol       Date:  2016-11-02       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.